WE NUKE CANCER
"WE NUKE CANCER" is a word mark owned by Actinium Pharmaceuticals, Inc., filed at the UKIPO on September 14, 2026. It is filed and waiting for examination and covers classes 5 and 42.
- Status
- Filed
- Since September 14, 2026
- Filed
- September 14, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- UK00004445014
- Registration no.
- UK00004445014
- Office
- UKIPO
- Intellectual Property Office
- Mark type
- Word mark
- 2 classes
Who owns WE NUKE CANCER
The owner and representative on file with the office.
Owner
Actinium Pharmaceuticals, Inc.
United States
Representative
Dentons UK and Middle East LLP
Dentons UK and Middle East LLP
What the mark covers
The products and services WE NUKE CANCER is filed for, grouped by Nice class.
Medicinal preparations for use in oncology; pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; radiopharmaceutical preparations for the treatment of cancer.
Scientific research and development; Pharmaceutical research and development; Research and development of antibodies; Research and development of medicines; Research and development of new products; Research and development of conjugated antibodies; Research and development in the field of pharmaceuticals; Research and development of advanced learning technologies and teaching methods; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer.
About WE NUKE CANCER
Who owns the trademark "WE NUKE CANCER"?
The UKIPO trademark "WE NUKE CANCER" (application UK00004445014) is owned by Actinium Pharmaceuticals, Inc.
What is the status of "WE NUKE CANCER"?
Its status at the UKIPO is: filed.
Get this data via the API
Everything on this page comes from the Signa API. Pull WE NUKE CANCER and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a0a321-2e56-721b-832d-abac3289c78a
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a0a321-2e56-721b-832d-abac3289c78a",
"object": "trademark",
"mark_text": "WE NUKE CANCER",
"status": {
"primary": "pending",
"stage": "filed"
},
"office_code": "GB",
"application_number": "UK00004445014",
"filing_date": "2026-09-14",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "Actinium Pharmaceuticals, Inc.",
"entity_id": null
}
]
}